DCR After PRRT
| Parameter | DCR* | P |
|---|---|---|
| Overall | 0.57 (0.42–0.71) | |
| Sex | ||
| Female | 0.60 (0.37–0.79) | 0.72 |
| Male | 0.55 (0.34–0.74) | |
| Age at therapy (y) | ||
| ≤64 | 0.71 (0.50–0.86) | 0.06 |
| >64 | 0.39 (0.19–0.63) | |
| Histologic grade | ||
| G1 | 0.64 (0.33–0.86) | 0.50 |
| G2–G3 | 0.50 (0.32–0.68) | |
| 68Ga-PET uptake | ||
| 3 | 0.57 (0.22–0.86) | 1 |
| 4 | 0.57 (0.40–0.73) | |
| Surgery | ||
| ≤1 | 0.71 (0.45–0.88) | 0.21 |
| ≥2 | 0.48 (0.29–0.67) | |
| Radiotherapy cycles | ||
| ≤1 | 0.59 (0.40–0.76) | 0.75 |
| ≥2 | 0.53 (0.29–0.76) | |
| Concomitant therapy | ||
| No | 0.80 (0.45–0.95) | 0.15 |
| Yes | 0.50 (0.33–0.67) | |
| Disease extension | ||
| Moderate | 0.75 (0.48–0.91) | 0.10 |
| Extended | 0.46 (0.27–0.66) | |
| ECOG PS | ||
| 0 | 0.65 (0.42–0.83) | 0.37 |
| 1–2 | 0.50 (0.30–0.70) | |
| Neurologic symptoms | ||
| No | 0.63 (0.28–0.88) | 1 |
| Yes | 0.56 (0.38–0.72) |
↵* 95% CI in parentheses.
ECOG = Eastern Cooperative Oncology Group.